Pharmaceuticals Targeting Nonsense Mutations in Genetic Diseases: Progress in Development

ISSN： 1173-8804

Source： BioDrugs, Vol.23, Iss.3, 2009-06, pp. : 165-174

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Portal Vein Embolization: Impact of Chemotherapy and Genetic Mutations

By Deipolyi Amy R. Zhang Yu Shrike Khademhosseini Ali Naidu Sailendra Borad Mitesh Sahin Burcu Mathur Amit K. Oklu Rahmi

Journal of Clinical Medicine, Vol. 6, Iss. 3, 2017-03 ,pp. : 26-26

MDPI

Access to resources Recommend Favorite

Understanding and Applying Regulatory Guidance on the Nonclinical Development of Biotechnology-Derived Pharmaceuticals

By Snodin David J.

BioDrugs, Vol. 20, Iss. 1, 2006-01 ,pp. : 25-52

Adis International

Access to resources Recommend Favorite

Progress and Challenges towards the Development of Malaria Vaccines

By Tetteh Kevin K.A. Polley Spencer D.

BioDrugs, Vol. 21, Iss. 6, 2007-01 ,pp. : 357-373

Adis International

Access to resources Recommend Favorite

Current Advances in the Development of Anticancer Drugs Targeting Tyrosine Kinases of the Src Family

Current Drug Therapy, Vol. 3, Iss. 3, 2008-09 ,pp. : 158-176

Bentham Science Publishers

Access to resources Recommend Favorite

Progress in the Development of Immune-Based Therapies for Type 1 Diabetes Mellitus

By Matthias von Herrath Rottembourg Diane Bresson Damien

BioDrugs, Vol. 20, Iss. 6, 2006-01 ,pp. : 341-350

Adis International

Access to resources Recommend Favorite